This Week in Nature

In this week's Nature, a team led by researchers from St. Jude Children's Research Hospital reports an in-depth investigation into the genetics of medulloblastoma, the most common form of childhood brain cancer. By analyzing the genome sequences of 491 medulloblastomas and focusing on altered gene expression in another 1,256 samples, the scientists uncovered novel genetic alterations that drive the disease, including many that specific to different subgroups.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.